Skip to content

Clinical observation on the treatment of breast cancer related lymphedema with oral and external use of the ZhuShui Decoction

Clinical observation on the treatment of breast cancer related lymphedema with oral and external use of the ZhuShui Decoction

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200005626
Enrollment
Unknown
Registered
2022-02-09
Start date
2022-03-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

Treatment group control group:Zhushui Decoction
control group:Air pressure wave therapeutic instrument

Sponsors

Shanghai Hospital of traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria (1) Older than 18 years old; (2) breast cancer surgery has been performed, including modified radical mastectomy, radical mastectomy and breast conserving surgery. (3) there is a clear history of lymph node dissection for breast cancer. (4) Meet the diagnostic criteria of upper limb edema after breast cancer surgery; (5) The disease stage accorded with grade I - III, and there was no acute skin infection and cellulitis; (6) Karnofsky score = 60; (7) The expected survival time is more than 3 months.

Exclusion criteria

Exclusion criteria: Exclusion criteria (1) Severe allergy; (2) Compression of other tumors, recurrence and metastasis of tumors in the upper arm, upper and lower clavicles or armpits, resulting in compression of veins and lymphatic vessels, and limb edema is not caused by lymph node dissection; (3) There are severe skin lesions such as macula, eczema, mound infiltration, erythema and exfoliative dermatitis on the local skin of the affected limb; (4) The affected limb has thrombotic disease, phlebitis, lymphangitis and other vascular and lymphatic diseases; (5) It is complicated with serious primary diseases such as heart, cerebrovascular, liver, kidney and hematopoietic system.

Design outcomes

Primary

MeasureTime frame
blood;Arm circumference;

Contacts

Public ContactXu Jing
purplepersonal@sina.com13916281861

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026